Optimal levetiracetam dosage regimen for preventing seizures related to immune effector cell-associated neurotoxicity syndrome

Yuri Sugimoto, Yuichi Tsuchiya, Yudai Wada, Nanae Yamamoto, Hoyumi Uematsu, Daisuke Kobayashi, Takuji Yamauchi, Fumiaki Jinnouchi, Teppei Sakoda, Kohta Miyawaki, Takahiro Shima, Ken Takigawa, Masatoshi Shimo, Yoshikane Kikushige, Yasuo Mori, Satoshi Nakao, Takahiro Nakamura, Masatoshi Mine, Koichi Akashi, Takeshi Hirota, Mayako Uchida, Koji Kato
Bone Marrow Transplantation · Springer Nature · 2026-11-14 · DOI: 10.1038/s41409-026-03038-1

Аннотация

Bone Marrow Transplantation, Published online: 14 November 2026; doi:10.1038/s41409-026-03038-1 Optimal levetiracetam dosage regimen for preventing seizures related to immune effector cell-associated neurotoxicity syndrome

Читать у издателя →

Похожие статьи